Mggm LLC

Major Depressive Disorder

Mggm LLC’s clinical research activity is centered on major depression and the evaluation of treatments for major depressive disorder, with a focus on patients who have not responded adequately to ongoing antidepressant therapy.

  • Depressive symptom reduction
  • MADRS total score assessment
  • Treatment-resistant depression

The sponsor’s trial portfolio reflects interest in therapeutic approaches aimed at improving mood symptoms and overall clinical response in adult psychiatric care.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness and Safety of REL-1017 for Patients with Major Depression Who Have Not Responded to Current Treatment

    Not recruiting

    3 1
    Investigated diseases:
    Italy